首页> 外文期刊>The FEBS journal >Positive lymph-node breast cancer patients - activation of NF-kappa B in tumor-associated leukocytes stimulates cytokine secretion that promotes metastasis via C-C chemokine receptor CCR7
【24h】

Positive lymph-node breast cancer patients - activation of NF-kappa B in tumor-associated leukocytes stimulates cytokine secretion that promotes metastasis via C-C chemokine receptor CCR7

机译:淋巴结阳性乳腺癌患者-肿瘤相关白细胞中NF-κB的激活可刺激细胞因子分泌,并通过C-C趋化因子受体CCR7促进转移

获取原文
获取原文并翻译 | 示例
           

摘要

Tumor metastasis to lymph nodes is most deadly complication among breast cancer patients. Herein, we investigated the molecular mechanism by which tumor-associated leukocytes (TALs) mediate lymph node metastasis. The density of different leukocyte subtypes infiltrating the tumor microenvironment of negative and positive lymph nodes (nLNs, pLNs) in breast cancer patients was measured using immunohistochemistry. In addition, we isolated TALs from blood drained from the axillary tributaries of nLN and pLN patients during breast surgery. Secretions of TALs were subjected to cytokine profiling using a cytokine antibody array. Our results showed an increase in the number of infiltrated CD45+ cells in the carcinoma tissues of pLN patients with the major proportion being myeloid subsets compared with nLN patients. Furthermore, TALs of pLN patients show a significant fivefold increase in the secretion of interleukin (IL)-1 alpha, interferon-gamma, IL-5, IL-3 and tumor necrosis factor-beta, and are characterized by enhanced constitutive NF-kappa B/p65 signaling compared with TALs isolated from nLN patients. Using an invasion assay, cytokines secreted by TALs of pLN patients were shown to augment the invasive phenotype of breast cancer MCF-7 and SKBR3 cells compared with nLN patients. Using flow cytometry, we found that C-C chemokine receptor 7 (CCR7) is significantly overexpressed in breast carcinoma of pLN patients compared with nLNs patients. Intriguingly, CCR7, a mechanistic clue for metastasis, is upregulated in MCF-7 cells upon stimulation with TAL-conditioned media of pLN patients. Our findings show that the molecular cues secreted by TALs alone or in combination with CCR7 may emerge as future therapeutic targets for lymph node metastasis in breast cancer patients.
机译:肿瘤转移至淋巴结是乳腺癌患者中最致命的并发症。在本文中,我们研究了肿瘤相关白细胞(TAL)介导淋巴结转移的分子机制。使用免疫组织化学方法测量了浸润阴性和阳性淋巴结(nLNs,pLNs)肿瘤微环境的不同白细胞亚型的密度。此外,我们从乳房手术期间从nLN和pLN患者的腋下支流排出的血液中分离了TAL。使用细胞因子抗体阵列对TAL的分泌物进行细胞因子分析。我们的结果显示,与nLN患者相比,pLN患者的癌组织中浸润的CD45 +细胞数量增加,主要比例是髓样亚型。此外,pLN患者的TALs显示白介素(IL)-1α,干扰素-γ,IL-5,IL-3和肿瘤坏死因子-β的分泌显着增加了五倍,并且其特征在于本构性NF-κB增强与从nLN患者分离的TALs相比,B / p65信号转导。使用侵袭试验,与nLN患者相比,pLN患者的TALs分泌的细胞因子显示出可增强乳腺癌MCF-7和SKBR3细胞的侵袭性表型。使用流式细胞仪,我们发现与nLNs患者相比,pLN患者的乳腺癌中C-C趋化因子受体7(CCR7)明显过表达。有趣的是,在pLN患者的TAL条件培养基刺激下,MCF-7细胞中的转移机制提示CCR7被上调。我们的发现表明,TALs单独或与CCR7结合分泌的分子线索可能会成为乳腺癌患者淋巴结转移的未来治疗靶点。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号